ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Argatroban Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: May 2025
|
Report Code: QYRE-Auto-16160
Home | Market Reports | Health| Pharmacy
Global Argatroban Market Insights and Forecast to 2028
BUY CHAPTERS

Global Argatroban Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-16160
Report
May 2025
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Sandoz Inc
GlaxoSmithKline PLC
Fresenius Kabi
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
Eagle Pharmaceuticals Inc.
WEST-WARD,INC

Argatroban Market Size

In 2024, the global market size of Argatroban was estimated to be worth US$ 56.2 million and is forecast to reach approximately US$ 37.8 million by 2031 with a CAGR of -5.6% during the forecast period 2025-2031.

Argatroban Market

Argatroban Market

Argatroban is a synthetic direct thrombin inhibitor and the chemical name is 1-[5- [(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid, monohydrate. Argatroban has 4 asymmetric carbons. One of the asymmetric carbons has an R configuration (stereoisomer Type I) and an S configuration (stereoisomer Type II). Argatroban consists of a mixture of R and S stereoisomers at a ratio of approximately 65:35.
Global Argatroban key players include Mitsubishi Tanabe Pharma, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, SANDOZ, etc. Global top four manufacturers hold a share nearly 60%.
Japan is the largest market, with a share about 35%, followed by Europe, and USA, both have a share about 55 percent.
In terms of product, Argatroban Injection is the largest segment, with a share over 70%. And in terms of application, the largest application is Heparin-induced thrombocytopenia (HIT), followed by Percutaneous Coronary Intervention, Cerebral arterial thrombosis.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Argatroban, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Argatroban.
The Argatroban market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Argatroban market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Argatroban manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Argatroban Market Report

Report Metric Details
Report Name Argatroban Market
Forecasted market size in 2031 approximately US$ 37.8 million
Forecasted years 2025 - 2031
Segment by Type
  • Argatroban Powder
  • Argatroban Injection
Segment by Application
  • Heparin-induced Thrombocytopenia (HIT)
  • Percutaneous Coronary Intervention
  • Cerebral Arterial Thrombosis
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd, WEST-WARD,INC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Argatroban in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Argatroban manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Argatroban sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Argatroban Market size in 2031?

Ans: The Argatroban Market size in 2031 will be approximately US$ 37.8 million.

What is the market share of major companies in Argatroban Market?

Ans: Global top four manufacturers hold a share nearly 60%.

What is the Argatroban Market share by type?

Ans: In terms of product, Argatroban Injection is the largest segment, with a share over 70%.

Who are the main players in the Argatroban Market report?

Ans: The main players in the Argatroban Market are Pfizer, Inc, SANDOZ, GlaxoSmithKline Plc, fresenius-kabi, Eagle Pharmaceuticals, Inc, Mitsubishi Tanabe Pharma, Teva Pharmaceutical Industries Ltd, WEST-WARD,INC

What are the Application segmentation covered in the Argatroban Market report?

Ans: The Applications covered in the Argatroban Market report are Heparin-induced Thrombocytopenia (HIT), Percutaneous Coronary Intervention, Cerebral Arterial Thrombosis

What are the Type segmentation covered in the Argatroban Market report?

Ans: The Types covered in the Argatroban Market report are Argatroban Powder, Argatroban Injection

Recommended Reports

Thrombosis & Stroke

Thrombin & Anticoagulants

Cardiovascular APIs

Market trends :

Topic Trends
Global the global argatroban market is experiencing a declining trend with a negative cagr, driven by reduced demand and market contraction across major regions.
Type Argatroban Powder - argatroban powder remains a niche segment with limited market share compared to injections.
Argatroban Injection - argatroban injection dominates the market, accounting for over 70% of global sales due to clinical preference and established usage.
Application Heparin-induced Thrombocytopenia (HIT) - heparin-induced thrombocytopenia (hit) is the primary application for argatroban, driving the majority of product demand.
Percutaneous Coronary Intervention - percutaneous coronary intervention remains a secondary but stable application for argatroban usage.
Cerebral Arterial Thrombosis - cerebral arterial thrombosis represents a smaller but consistent application segment for argatroban.
Company Pfizer - pfizer remains a key player in the argatroban market, maintaining its position among the top manufacturers globally.
SANDOZ - sandoz continues to hold significant market share in the argatroban segment, contributing to the global supply chain.
Mitsubishi Tanabe Pharma - mitsubishi tanabe pharma leads the argatroban market, especially in japan, with a strong manufacturing and distribution presence.
Teva Pharmaceutical Industries Ltd - teva pharmaceutical industries ltd is among the top four global manufacturers, supporting market stability.
Region North America - north america maintains a significant share in the argatroban market, supported by established healthcare infrastructure.
EMEA - emea region, particularly europe, continues to be a major market for argatroban with steady demand.
APAC - apac, led by japan, is the largest regional market for argatroban, accounting for approximately 35% of global sales.
LATAM - latam holds a smaller share in the global argatroban market with limited but stable demand.
1 Study Coverage
1.1 Argatroban Product Introduction
1.2 Market by Type
1.2.1 Global Argatroban Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Argatroban Powder
1.2.3 Argatroban Injection
1.3 Market by Application
1.3.1 Global Argatroban Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Heparin-induced Thrombocytopenia (HIT)
1.3.3 Percutaneous Coronary Intervention
1.3.4 Cerebral Arterial Thrombosis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Argatroban Market Size Estimates and Forecasts
2.1.1 Global Argatroban Revenue 2020-2031
2.1.2 Global Argatroban Sales 2020-2031
2.2 Argatroban Market Size by Region: 2024 Versus 2031
2.3 Argatroban Sales by Region (2020-2031)
2.3.1 Global Argatroban Sales by Region: 2020-2025
2.3.2 Global Argatroban Sales Forecast by Region (2026-2031)
2.3.3 Global Argatroban Sales Market Share by Region (2020-2031)
2.4 Argatroban Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Argatroban Revenue by Region: 2020-2025
2.4.2 Global Argatroban Revenue Forecast by Region (2026-2031)
2.4.3 Global Argatroban Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Argatroban Sales by Type (2020-2031)
3.1.1.1 Global Argatroban Sales Volume by Type (2020-2031)
3.1.1.2 Global Argatroban Sales Market Share by Type (2020-2031)
3.1.2 Global Argatroban Revenue by Type (2020-2031)
3.1.2.1 Global Argatroban Revenue by Type (2020-2031)
3.1.2.2 Global Argatroban Revenue Market Share by Type (2020-2031)
3.1.3 Argatroban Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Argatroban Sales by Application (2020-2031)
3.2.1.1 Global Argatroban Sales Volume by Application (2020-2031)
3.2.1.2 Global Argatroban Sales Market Share by Application (2020-2031)
3.2.2 Global Argatroban Revenue by Application (2020-2031)
3.2.2.1 Global Argatroban Revenue by Application (2020-2031)
3.2.2.2 Global Argatroban Revenue Market Share by Application (2020-2031)
3.2.3 Argatroban Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Argatroban Powder of Argatroban Revenue Market Share by Application
3.3.2 Argatroban Injection of Argatroban Revenue Market Share by Application
4 Global Argatroban by Manufacturers
4.1 Global Top Argatroban Manufacturers by Sales (2020-2025)
4.1.1 Global Argatroban Sales by Manufacturer (2020-2025)
4.1.2 Global Argatroban Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Argatroban Manufacturers by Revenue (2020-2025)
4.2.1 Global Argatroban Revenue by Manufacturer (2020-2025)
4.2.2 Global Argatroban Revenue Share by Manufacturer (2020-2025)
4.3 Global Argatroban Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Argatroban Manufacturers Covered: Ranking by Revenue
4.4.2 Global Argatroban Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Argatroban Manufacturing Base Distribution, Product Type
4.5.1 Argatroban Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Argatroban Market
4.5.3 Manufacturers Argatroban Product Type and Application
4.5.4 Argatroban Powder Market Sales of Argatroban by Manufacturer
4.5.5 Argatroban Injection Market Sales of Argatroban by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Pfizer, Inc
5.1.1 Pfizer, Inc Company Information
5.1.2 Pfizer, Inc Description, Business Overview
5.1.3 Pfizer, Inc Argatroban Products Offered
5.1.4 Pfizer, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Pfizer, Inc Argatroban Sales by Product in 2024
5.1.6 Pfizer, Inc Argatroban Sales by Application in 2024
5.1.7 Pfizer, Inc Argatroban Sales by Geographic Area in 2024
5.1.8 Pfizer, Inc Recent Developments
5.2 SANDOZ
5.2.1 SANDOZ Company Information
5.2.2 SANDOZ Description, Business Overview
5.2.3 SANDOZ Argatroban Products Offered
5.2.4 SANDOZ Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.2.5 SANDOZ Argatroban Sales by Product in 2024
5.2.6 SANDOZ Argatroban Sales by Application in 2024
5.2.7 SANDOZ Argatroban Sales by Geographic Area in 2024
5.2.8 SANDOZ Recent Developments
5.3 GlaxoSmithKline Plc
5.3.1 GlaxoSmithKline Plc Company Information
5.3.2 GlaxoSmithKline Plc Description, Business Overview
5.3.3 GlaxoSmithKline Plc Argatroban Products Offered
5.3.4 GlaxoSmithKline Plc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.3.5 GlaxoSmithKline Plc Argatroban Sales by Product in 2024
5.3.6 GlaxoSmithKline Plc Argatroban Sales by Application in 2024
5.3.7 GlaxoSmithKline Plc Argatroban Sales by Geographic Area in 2024
5.3.8 GlaxoSmithKline Plc Recent Developments
5.4 fresenius-kabi
5.4.1 fresenius-kabi Company Information
5.4.2 fresenius-kabi Description, Business Overview
5.4.3 fresenius-kabi Argatroban Products Offered
5.4.4 fresenius-kabi Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.4.5 fresenius-kabi Argatroban Sales by Product in 2024
5.4.6 fresenius-kabi Argatroban Sales by Application in 2024
5.4.7 fresenius-kabi Argatroban Sales by Geographic Area in 2024
5.4.8 fresenius-kabi Recent Developments
5.5 Eagle Pharmaceuticals, Inc
5.5.1 Eagle Pharmaceuticals, Inc Company Information
5.5.2 Eagle Pharmaceuticals, Inc Description, Business Overview
5.5.3 Eagle Pharmaceuticals, Inc Argatroban Products Offered
5.5.4 Eagle Pharmaceuticals, Inc Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Eagle Pharmaceuticals, Inc Argatroban Sales by Product in 2024
5.5.6 Eagle Pharmaceuticals, Inc Argatroban Sales by Application in 2024
5.5.7 Eagle Pharmaceuticals, Inc Argatroban Sales by Geographic Area in 2024
5.5.8 Eagle Pharmaceuticals, Inc Recent Developments
5.6 Mitsubishi Tanabe Pharma
5.6.1 Mitsubishi Tanabe Pharma Company Information
5.6.2 Mitsubishi Tanabe Pharma Description, Business Overview
5.6.3 Mitsubishi Tanabe Pharma Argatroban Products Offered
5.6.4 Mitsubishi Tanabe Pharma Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Mitsubishi Tanabe Pharma Argatroban Sales by Product in 2024
5.6.6 Mitsubishi Tanabe Pharma Argatroban Sales by Application in 2024
5.6.7 Mitsubishi Tanabe Pharma Argatroban Sales by Geographic Area in 2024
5.6.8 Mitsubishi Tanabe Pharma Recent Developments
5.7 Teva Pharmaceutical Industries Ltd
5.7.1 Teva Pharmaceutical Industries Ltd Company Information
5.7.2 Teva Pharmaceutical Industries Ltd Description, Business Overview
5.7.3 Teva Pharmaceutical Industries Ltd Argatroban Products Offered
5.7.4 Teva Pharmaceutical Industries Ltd Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Teva Pharmaceutical Industries Ltd Argatroban Sales by Product in 2024
5.7.6 Teva Pharmaceutical Industries Ltd Argatroban Sales by Application in 2024
5.7.7 Teva Pharmaceutical Industries Ltd Argatroban Sales by Geographic Area in 2024
5.7.8 Teva Pharmaceutical Industries Ltd Recent Developments
5.8 WEST-WARD,INC
5.8.1 WEST-WARD,INC Company Information
5.8.2 WEST-WARD,INC Description, Business Overview
5.8.3 WEST-WARD,INC Argatroban Products Offered
5.8.4 WEST-WARD,INC Argatroban Sales, Revenue and Gross Margin (2020-2025)
5.8.5 WEST-WARD,INC Argatroban Sales by Product in 2024
5.8.6 WEST-WARD,INC Argatroban Sales by Application in 2024
5.8.7 WEST-WARD,INC Argatroban Sales by Geographic Area in 2024
5.8.8 WEST-WARD,INC Recent Developments
6 North America
6.1 North America Argatroban Market Size YoY Growth 2020-2031
6.2 North America Argatroban Market Facts & Figures by Country
6.2.1 North America Argatroban Sales by Country (2020-2031)
6.2.2 North America Argatroban Revenue by Country (2020-2031)
6.3 North America Argatroban Sales by Type (2020-2025)
6.4 North America Argatroban Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Argatroban Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Argatroban Market Facts & Figures by Region
7.2.1 Asia-Pacific Argatroban Sales by Region (2020-2031)
7.2.2 Asia-Pacific Argatroban Revenue by Region (2020-2031)
7.3 Asia-Pacific Argatroban Sales by Type (2020-2025)
7.4 Asia-Pacific Argatroban Sales by Application (2020-2025)
8 Europe
8.1 Europe Argatroban Market Size YoY Growth 2020-2031
8.2 Europe Argatroban Market Facts & Figures by Country
8.2.1 Europe Argatroban Sales by Country (2020-2031)
8.2.2 Europe Argatroban Revenue by Country (2020-2031)
8.3 Europe Argatroban Sales by Type (2020-2025)
8.4 Europe Argatroban Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Argatroban Market Size YoY Growth 2020-2031
9.2 Latin America Argatroban Market Facts & Figures by Country
9.2.1 Latin America Argatroban Sales by Country (2020-2031)
9.2.2 Latin America Argatroban Revenue by Country (2020-2031)
9.3 Latin America Argatroban Sales by Type (2020-2025)
9.4 Latin America Argatroban Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Argatroban Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Argatroban Market Facts & Figures by Country
10.2.1 Middle East and Africa Argatroban Sales by Country (2020-2031)
10.2.2 Middle East and Africa Argatroban Revenue by Country (2020-2031)
10.3 Middle East and Africa Argatroban Sales by Type (2020-2025)
10.4 Middle East and Africa Argatroban Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Argatroban Supply Chain Analysis
11.2 Argatroban Key Raw Materials and Upstream Suppliers
11.3 Argatroban Clients Analysis
11.4 Argatroban Sales Channel and Sales Model Analysis
11.4.1 Argatroban Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Argatroban Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Argatroban Distributors
12 Argatroban Market Dynamics
12.1 Argatroban Industry Trends
12.2 Argatroban Market Drivers
12.3 Argatroban Market Challenges
12.4 Argatroban Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Sandoz Inc
GlaxoSmithKline PLC
Fresenius Kabi
Mitsubishi Tanabe Pharma
Teva Pharmaceutical Industries Ltd
Eagle Pharmaceuticals Inc.
WEST-WARD,INC
List of Tables
 Table 1. Global Argatroban Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Argatroban Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Argatroban Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Argatroban Sales by Region (2020-2025) & (g)
 Table 5. Global Argatroban Sales Forecast by Region (2026-2031) & (g)
 Table 6. Global Argatroban Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Argatroban Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Argatroban Sales Volume by Type (2020-2025) & (g)
 Table 9. Global Argatroban Sales Volume by Type (2026-2031) & (g)
 Table 10. Global Argatroban Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Argatroban Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Argatroban Sales Volume by Application (2020-2025) & (g)
 Table 13. Global Argatroban Sales Volume by Application (2026-2031) & (g)
 Table 14. Global Argatroban Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Argatroban Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Argatroban Sales by Manufacturer (2020-2025) & (g)
 Table 17. Global Argatroban Sales Share by Manufacturer (2020-2025)
 Table 18. Argatroban Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Argatroban Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Argatroban Price (2020-2025) & (USD/g)
 Table 21. Ranking of Global Top Argatroban Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Argatroban Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Argatroban by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Argatroban as of 2024)
 Table 24. Argatroban Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Argatroban Market
 Table 26. Manufacturers Argatroban Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Pfizer, Inc Company Information
 Table 29. Pfizer, Inc Description and Business Overview
 Table 30. Pfizer, Inc Argatroban Product
 Table 31. Pfizer, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 32. Pfizer, Inc Sales Proportion of Argatroban by Product in 2024
 Table 33. Pfizer, Inc Sales Proportion of Argatroban by Application in 2024
 Table 34. Pfizer, Inc Sales Proportion of Argatroban by Geographic Area in 2024
 Table 35. Pfizer, Inc Recent Developments
 Table 36. SANDOZ Company Information
 Table 37. SANDOZ Description and Business Overview
 Table 38. SANDOZ Argatroban Product
 Table 39. SANDOZ Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 40. SANDOZ Sales Proportion of Argatroban by Product in 2024
 Table 41. SANDOZ Sales Proportion of Argatroban by Application in 2024
 Table 42. SANDOZ Sales Proportion of Argatroban by Geographic Area in 2024
 Table 43. SANDOZ Recent Developments
 Table 44. GlaxoSmithKline Plc Company Information
 Table 45. GlaxoSmithKline Plc Description and Business Overview
 Table 46. GlaxoSmithKline Plc Argatroban Product
 Table 47. GlaxoSmithKline Plc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 48. GlaxoSmithKline Plc Sales Proportion of Argatroban by Product in 2024
 Table 49. GlaxoSmithKline Plc Sales Proportion of Argatroban by Application in 2024
 Table 50. GlaxoSmithKline Plc Sales Proportion of Argatroban by Geographic Area in 2024
 Table 51. GlaxoSmithKline Plc Recent Developments
 Table 52. fresenius-kabi Company Information
 Table 53. fresenius-kabi Description and Business Overview
 Table 54. fresenius-kabi Argatroban Product
 Table 55. fresenius-kabi Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 56. fresenius-kabi Sales Proportion of Argatroban by Product in 2024
 Table 57. fresenius-kabi Sales Proportion of Argatroban by Application in 2024
 Table 58. fresenius-kabi Sales Proportion of Argatroban by Geographic Area in 2024
 Table 59. fresenius-kabi Recent Developments
 Table 60. Eagle Pharmaceuticals, Inc Company Information
 Table 61. Eagle Pharmaceuticals, Inc Description and Business Overview
 Table 62. Eagle Pharmaceuticals, Inc Argatroban Product
 Table 63. Eagle Pharmaceuticals, Inc Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 64. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Product in 2024
 Table 65. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Application in 2024
 Table 66. Eagle Pharmaceuticals, Inc Sales Proportion of Argatroban by Geographic Area in 2024
 Table 67. Eagle Pharmaceuticals, Inc Recent Developments
 Table 68. Mitsubishi Tanabe Pharma Company Information
 Table 69. Mitsubishi Tanabe Pharma Description and Business Overview
 Table 70. Mitsubishi Tanabe Pharma Argatroban Product
 Table 71. Mitsubishi Tanabe Pharma Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 72. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Product in 2024
 Table 73. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Application in 2024
 Table 74. Mitsubishi Tanabe Pharma Sales Proportion of Argatroban by Geographic Area in 2024
 Table 75. Mitsubishi Tanabe Pharma Recent Developments
 Table 76. Teva Pharmaceutical Industries Ltd Company Information
 Table 77. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 78. Teva Pharmaceutical Industries Ltd Argatroban Product
 Table 79. Teva Pharmaceutical Industries Ltd Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 80. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Product in 2024
 Table 81. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Application in 2024
 Table 82. Teva Pharmaceutical Industries Ltd Sales Proportion of Argatroban by Geographic Area in 2024
 Table 83. Teva Pharmaceutical Industries Ltd Recent Developments
 Table 84. WEST-WARD,INC Company Information
 Table 85. WEST-WARD,INC Description and Business Overview
 Table 86. WEST-WARD,INC Argatroban Product
 Table 87. WEST-WARD,INC Argatroban Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)
 Table 88. WEST-WARD,INC Sales Proportion of Argatroban by Product in 2024
 Table 89. WEST-WARD,INC Sales Proportion of Argatroban by Application in 2024
 Table 90. WEST-WARD,INC Sales Proportion of Argatroban by Geographic Area in 2024
 Table 91. WEST-WARD,INC Recent Developments
 Table 92. North America Argatroban Sales by Country (2020-2025) & (g)
 Table 93. North America Argatroban Sales by Country (2026-2031) & (g)
 Table 94. North America Argatroban Revenue by Country (2020-2025) & (US$ Million)
 Table 95. North America Argatroban Revenue by Country (2026-2031) & (US$ Million)
 Table 96. North America Argatroban Sales by Type (2020-2025) & (g)
 Table 97. North America Argatroban Sales by Application (2020-2025) & (g)
 Table 98. Asia-Pacific Argatroban Sales by Region (2020-2025) & (g)
 Table 99. Asia-Pacific Argatroban Sales by Region (2026-2031) & (g)
 Table 100. Asia-Pacific Argatroban Revenue by Region (2020-2025) & (US$ Million)
 Table 101. Asia-Pacific Argatroban Revenue by Region (2026-2031) & (US$ Million)
 Table 102. Asia-Pacific Argatroban Sales by Type (2020-2025) & (g)
 Table 103. Asia-Pacific Argatroban Sales by Application (2020-2025) & (g)
 Table 104. Europe Argatroban Sales by Country (2020-2025) & (g)
 Table 105. Europe Argatroban Sales by Country (2026-2031) & (g)
 Table 106. Europe Argatroban Revenue by Country (2020-2025) & (US$ Million)
 Table 107. Europe Argatroban Revenue by Country (2026-2031) & (US$ Million)
 Table 108. Europe Argatroban Sales by Type (2020-2025) & (g)
 Table 109. Europe Argatroban Sales by Application (2020-2025) & (g)
 Table 110. Latin America Argatroban Sales by Country (2020-2025) & (g)
 Table 111. Latin America Argatroban Sales by Country (2026-2031) & (g)
 Table 112. Latin America Argatroban Revenue by Country (2020-2025) & (US$ Million)
 Table 113. Latin America Argatroban Revenue by Country (2026-2031) & (US$ Million)
 Table 114. Latin America Argatroban Sales by Type (2020-2025) & (g)
 Table 115. Latin America Argatroban Sales by Application (2020-2025) & (g)
 Table 116. Middle East and Africa Argatroban Sales by Country (2020-2025) & (g)
 Table 117. Middle East and Africa Argatroban Sales by Country (2026-2031) & (g)
 Table 118. Middle East and Africa Argatroban Revenue by Country (2020-2025) & (US$ Million)
 Table 119. Middle East and Africa Argatroban Revenue by Country (2026-2031) & (US$ Million)
 Table 120. Middle East and Africa Argatroban Sales by Type (2020-2025) & (g)
 Table 121. Middle East and Africa Argatroban Sales by Application (2020-2025) & (g)
 Table 122. Argatroban Key Raw Materials, Industry Status and Trend
 Table 123. Argatroban Key Raw Materials and Upstream Suppliers
 Table 124. Argatroban Clients Status and Trend
 Table 125. Argatroban Typical Clients
 Table 126. Argatroban Distributors
 Table 127. Argatroban Market Trends
 Table 128. Argatroban Market Drivers
 Table 129. Argatroban Market Challenges
 Table 130. Argatroban Market Restraints
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Argatroban Product Picture
 Figure 2. Global Argatroban Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Argatroban Sales Market Share by Type in 2024 & 2031
 Figure 4. Argatroban Powder Product Picture
 Figure 5. Argatroban Injection Product Picture
 Figure 6. Global Argatroban Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Argatroban Sales Market Share by Application in 2024 & 2031
 Figure 8. Heparin-induced Thrombocytopenia (HIT)
 Figure 9. Percutaneous Coronary Intervention
 Figure 10. Cerebral Arterial Thrombosis
 Figure 11. Argatroban Report Years Considered
 Figure 12. Global Argatroban Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Argatroban Market Size 2020-2031 (US$ Million)
 Figure 14. Global Argatroban Sales 2020-2031 (g)
 Figure 15. Global Argatroban Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Argatroban Revenue Market Share by Region (2020-2031)
 Figure 17. Global Argatroban Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Argatroban Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Argatroban Average Selling Price (ASP) by Type (2020-2025) & (USD/g)
 Figure 20. Global Argatroban Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Argatroban Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Argatroban Average Selling Price (ASP) by Application (2020-2025) & (USD/g)
 Figure 23. Argatroban Powder of Argatroban Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Argatroban Injection of Argatroban Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Argatroban Sales Share by Manufacturer in 2024
 Figure 26. Argatroban Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Argatroban Powder Market Sales Proportion by Manufacturer in 2024
 Figure 28. Argatroban Injection Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Argatroban Revenue 2020-2031 (US$ Million)
 Figure 30. North America Argatroban Sales Market Share by Type (2020-2025)
 Figure 31. North America Argatroban Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Argatroban Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Argatroban Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Argatroban Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Argatroban Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Argatroban Sales Market Share by Application (2020-2025)
 Figure 37. Europe Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Argatroban Sales Market Share by Country (2020-2031)
 Figure 39. Europe Argatroban Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Argatroban Sales Market Share by Type (2020-2025)
 Figure 41. Europe Argatroban Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Argatroban Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Argatroban Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Argatroban Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Argatroban Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Argatroban Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Argatroban Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Argatroban Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Argatroban Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Argatroban Sales Market Share by Application (2020-2025)
 Figure 52. Argatroban Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Argatroban Raw Materials by Region in 2024
 Figure 54. Argatroban Distribution Channels
 Figure 55. Global Argatroban Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Argatroban Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Thrombin Inhibitor Market Research Report 2024
Global Direct Thrombin Inhibitors DTIs Market Research Report 2024
Thrombin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ozagrel Market Research Report 2024
Global Rivaroxaban Drugs Market Research Report 2024
Global Dabigatran Market Insights Forecast to 2030
Global Rivaroxaban Market Insights Forecast to 2030
Global Hirudin Market Insights Forecast to 2030
Global Argatroban Injection Market Research Report 2024
Recombinant Hirudin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dabigatran Etexilate Mesylate Market Research Report 2024
Global Tranexamic Acid Market Research Report 2025
Global Edoxaban Tosilate Tablets and Generic Drugs Market Research Report 2024
Global Edoxaban Reagent Market Research Report 2024
Global Dabigatran Dabigatran Generic Drugs Market Research Report 2024
Global Anticoagulant Drugs Market Insights Forecast to 2030
Global Direct Oral Anticoagulant Market Insights Forecast to 2030
Global Retigabine Market Research Report 2024
Global Antipain Dihydrochloride Market Research Report 2024
Global Direct Oral Anticoagulants DOACs Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions